nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—Abnormal faeces—Hydrochlorothiazide—nephrolithiasis	0.0294	0.0486	CcSEcCtD
Octreotide—SSTR4—G alpha (i) signalling events—RGS14—nephrolithiasis	0.0207	0.0523	CbGpPWpGaD
Octreotide—Intraocular pressure increased—Hydrochlorothiazide—nephrolithiasis	0.0191	0.0316	CcSEcCtD
Octreotide—Trauma—Hydrochlorothiazide—nephrolithiasis	0.0176	0.0292	CcSEcCtD
Octreotide—Epigastric pain—Hydrochlorothiazide—nephrolithiasis	0.0174	0.0288	CcSEcCtD
Octreotide—Sinus bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0171	0.0283	CcSEcCtD
Octreotide—Anorectal disorder—Hydrochlorothiazide—nephrolithiasis	0.016	0.0264	CcSEcCtD
Octreotide—Creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.016	0.0264	CcSEcCtD
Octreotide—SSTR3—G alpha (i) signalling events—RGS14—nephrolithiasis	0.0157	0.0396	CbGpPWpGaD
Octreotide—SSTR1—G alpha (i) signalling events—RGS14—nephrolithiasis	0.015	0.038	CbGpPWpGaD
Octreotide—SSTR5—G alpha (i) signalling events—RGS14—nephrolithiasis	0.0133	0.0337	CbGpPWpGaD
Octreotide—SSTR2—GPCRs, Other—CHRM3—nephrolithiasis	0.0128	0.0324	CbGpPWpGaD
Octreotide—Peptic ulcer—Hydrochlorothiazide—nephrolithiasis	0.0126	0.0208	CcSEcCtD
Octreotide—SSTR2—G alpha (i) signalling events—RGS14—nephrolithiasis	0.0123	0.0311	CbGpPWpGaD
Octreotide—Blood creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0202	CcSEcCtD
Octreotide—Stinging—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0172	CcSEcCtD
Octreotide—Numbness—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0168	CcSEcCtD
Octreotide—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.00969	0.016	CcSEcCtD
Octreotide—Jaundice cholestatic—Hydrochlorothiazide—nephrolithiasis	0.00956	0.0158	CcSEcCtD
Octreotide—SSTR4—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00937	0.0237	CbGpPWpGaD
Octreotide—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.00825	0.0137	CcSEcCtD
Octreotide—Wheezing—Hydrochlorothiazide—nephrolithiasis	0.00816	0.0135	CcSEcCtD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00803	0.0203	CbGpPWpGaD
Octreotide—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.00759	0.0126	CcSEcCtD
Octreotide—SSTR3—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.0071	0.0179	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—RGS14—nephrolithiasis	0.00708	0.0179	CbGpPWpGaD
Octreotide—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.00704	0.0117	CcSEcCtD
Octreotide—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.00701	0.0116	CcSEcCtD
Octreotide—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.00694	0.0115	CcSEcCtD
Octreotide—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.00688	0.0114	CcSEcCtD
Octreotide—SSTR1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00681	0.0172	CbGpPWpGaD
Octreotide—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.00669	0.0111	CcSEcCtD
Octreotide—Injury—Hydrochlorothiazide—nephrolithiasis	0.00663	0.011	CcSEcCtD
Octreotide—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.00652	0.0108	CcSEcCtD
Octreotide—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.00646	0.0107	CcSEcCtD
Octreotide—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.00643	0.0106	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—RGS14—nephrolithiasis	0.00643	0.0162	CbGpPWpGaD
Octreotide—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00627	0.0104	CcSEcCtD
Octreotide—SSTR4—GPCR ligand binding—CHRM3—nephrolithiasis	0.00612	0.0155	CbGpPWpGaD
Octreotide—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.0061	0.0101	CcSEcCtD
Octreotide—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.0061	0.0101	CcSEcCtD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00609	0.0154	CbGpPWpGaD
Octreotide—SSTR5—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00604	0.0153	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00583	0.0147	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—PTH—nephrolithiasis	0.00559	0.0141	CbGpPWpGaD
Octreotide—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00559	0.00925	CcSEcCtD
Octreotide—SSTR2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00557	0.0141	CbGpPWpGaD
Octreotide—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.00557	0.00921	CcSEcCtD
Octreotide—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.00549	0.00909	CcSEcCtD
Octreotide—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.0054	0.00893	CcSEcCtD
Octreotide—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00538	0.0089	CcSEcCtD
Octreotide—SSTR3—GPCR downstream signaling—RGS14—nephrolithiasis	0.00536	0.0136	CbGpPWpGaD
Octreotide—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.0053	0.00878	CcSEcCtD
Octreotide—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00527	0.00872	CcSEcCtD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00517	0.0131	CbGpPWpGaD
Octreotide—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00517	0.00855	CcSEcCtD
Octreotide—SSTR1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00514	0.013	CbGpPWpGaD
Octreotide—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00493	0.00815	CcSEcCtD
Octreotide—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.0049	0.0081	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—RGS14—nephrolithiasis	0.00487	0.0123	CbGpPWpGaD
Octreotide—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00487	0.00806	CcSEcCtD
Octreotide—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.0048	0.00794	CcSEcCtD
Octreotide—SSTR4—GPCR downstream signaling—DGKH—nephrolithiasis	0.00478	0.0121	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00478	0.0121	CbGpPWpGaD
Octreotide—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00475	0.00787	CcSEcCtD
Octreotide—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00473	0.00782	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—RGS14—nephrolithiasis	0.00467	0.0118	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—CHRM3—nephrolithiasis	0.00463	0.0117	CbGpPWpGaD
Octreotide—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00461	0.00762	CcSEcCtD
Octreotide—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00458	0.00758	CcSEcCtD
Octreotide—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00457	0.00756	CcSEcCtD
Octreotide—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00457	0.00756	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—RGS14—nephrolithiasis	0.00456	0.0115	CbGpPWpGaD
Octreotide—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00448	0.00741	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—ADCY10—nephrolithiasis	0.00446	0.0113	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00444	0.0112	CbGpPWpGaD
Octreotide—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00443	0.00733	CcSEcCtD
Octreotide—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00441	0.00729	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—DGKH—nephrolithiasis	0.00434	0.011	CbGpPWpGaD
Octreotide—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00429	0.00711	CcSEcCtD
Octreotide—SSTR3—GPCR ligand binding—PTH—nephrolithiasis	0.00424	0.0107	CbGpPWpGaD
Octreotide—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00423	0.007	CcSEcCtD
Octreotide—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00422	0.00698	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—RGS14—nephrolithiasis	0.00421	0.0106	CbGpPWpGaD
Octreotide—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.0042	0.00694	CcSEcCtD
Octreotide—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00419	0.00693	CcSEcCtD
Octreotide—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00415	0.00688	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—RGS14—nephrolithiasis	0.00414	0.0105	CbGpPWpGaD
Octreotide—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00406	0.00673	CcSEcCtD
Octreotide—SSTR1—GPCR ligand binding—PTH—nephrolithiasis	0.00406	0.0103	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—CHRM3—nephrolithiasis	0.00394	0.00996	CbGpPWpGaD
Octreotide—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00393	0.00651	CcSEcCtD
Octreotide—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00391	0.00648	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—RGS14—nephrolithiasis	0.00382	0.00966	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—RGS14—nephrolithiasis	0.0038	0.00959	CbGpPWpGaD
Octreotide—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00377	0.00624	CcSEcCtD
Octreotide—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00373	0.00617	CcSEcCtD
Octreotide—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00367	0.00608	CcSEcCtD
Octreotide—SSTR2—GPCR ligand binding—CHRM3—nephrolithiasis	0.00364	0.00919	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—DGKH—nephrolithiasis	0.00362	0.00915	CbGpPWpGaD
Octreotide—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00362	0.00599	CcSEcCtD
Octreotide—SSTR5—GPCR ligand binding—PTH—nephrolithiasis	0.0036	0.00911	CbGpPWpGaD
Octreotide—Tension—Hydrochlorothiazide—nephrolithiasis	0.0036	0.00596	CcSEcCtD
Octreotide—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00357	0.0059	CcSEcCtD
Octreotide—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00355	0.00588	CcSEcCtD
Octreotide—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00353	0.00584	CcSEcCtD
Octreotide—SSTR1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00347	0.00878	CbGpPWpGaD
Octreotide—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00346	0.00573	CcSEcCtD
Octreotide—SSTR4—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00346	0.00873	CbGpPWpGaD
Octreotide—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00344	0.00569	CcSEcCtD
Octreotide—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00341	0.00564	CcSEcCtD
Octreotide—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00339	0.00562	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—ADCY10—nephrolithiasis	0.00338	0.00855	CbGpPWpGaD
Octreotide—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00337	0.00558	CcSEcCtD
Octreotide—SSTR2—GPCR ligand binding—PTH—nephrolithiasis	0.00333	0.0084	CbGpPWpGaD
Octreotide—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00331	0.00548	CcSEcCtD
Octreotide—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.0033	0.00546	CcSEcCtD
Octreotide—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00329	0.00545	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—DGKH—nephrolithiasis	0.00329	0.00831	CbGpPWpGaD
Octreotide—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00324	0.00537	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—ADCY10—nephrolithiasis	0.00324	0.0082	CbGpPWpGaD
Octreotide—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00323	0.00534	CcSEcCtD
Octreotide—Cough—Hydrochlorothiazide—nephrolithiasis	0.0032	0.0053	CcSEcCtD
Octreotide—SSTR4—GPCR downstream signaling—PTH—nephrolithiasis	0.00316	0.00799	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—DGKH—nephrolithiasis	0.00315	0.00797	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—CHRM3—nephrolithiasis	0.00314	0.00793	CbGpPWpGaD
Octreotide—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00313	0.00517	CcSEcCtD
Octreotide—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00313	0.00517	CcSEcCtD
Octreotide—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00313	0.00517	CcSEcCtD
Octreotide—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00311	0.00515	CcSEcCtD
Octreotide—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00309	0.00511	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—DGKH—nephrolithiasis	0.00308	0.00778	CbGpPWpGaD
Octreotide—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00306	0.00506	CcSEcCtD
Octreotide—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.003	0.00496	CcSEcCtD
Octreotide—Oedema—Hydrochlorothiazide—nephrolithiasis	0.003	0.00496	CcSEcCtD
Octreotide—Shock—Hydrochlorothiazide—nephrolithiasis	0.00295	0.00488	CcSEcCtD
Octreotide—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00293	0.00486	CcSEcCtD
Octreotide—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00292	0.00484	CcSEcCtD
Octreotide—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.0029	0.00479	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—RGS14—nephrolithiasis	0.00288	0.00727	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—ADCY10—nephrolithiasis	0.00288	0.00727	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—PTH—nephrolithiasis	0.00287	0.00725	CbGpPWpGaD
Octreotide—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00286	0.00473	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—DGKH—nephrolithiasis	0.00284	0.00718	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—DGKH—nephrolithiasis	0.0028	0.00707	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—RGS14—nephrolithiasis	0.00276	0.00697	CbGpPWpGaD
Octreotide—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00273	0.00452	CcSEcCtD
Octreotide—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00271	0.00448	CcSEcCtD
Octreotide—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00269	0.00445	CcSEcCtD
Octreotide—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00267	0.00442	CcSEcCtD
Octreotide—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00266	0.00441	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—ADCY10—nephrolithiasis	0.00266	0.00671	CbGpPWpGaD
Octreotide—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00264	0.00436	CcSEcCtD
Octreotide—SSTR3—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00262	0.00662	CbGpPWpGaD
Octreotide—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.0026	0.00431	CcSEcCtD
Octreotide—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00258	0.00428	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—DGKH—nephrolithiasis	0.00258	0.00652	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—DGKH—nephrolithiasis	0.00256	0.00648	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00256	0.00648	CbGpPWpGaD
Octreotide—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00256	0.00424	CcSEcCtD
Octreotide—Pain—Hydrochlorothiazide—nephrolithiasis	0.00256	0.00424	CcSEcCtD
Octreotide—SSTR1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00251	0.00634	CbGpPWpGaD
Octreotide—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00247	0.00409	CcSEcCtD
Octreotide—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00245	0.00405	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—RGS14—nephrolithiasis	0.00245	0.00618	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—PTH—nephrolithiasis	0.0024	0.00605	CbGpPWpGaD
Octreotide—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00238	0.00394	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—CHRM3—nephrolithiasis	0.00238	0.00601	CbGpPWpGaD
Octreotide—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00237	0.00392	CcSEcCtD
Octreotide—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00237	0.00392	CcSEcCtD
Octreotide—SSTR1—GPCR downstream signaling—PTH—nephrolithiasis	0.0023	0.0058	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CHRM3—nephrolithiasis	0.00228	0.00576	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—RGS14—nephrolithiasis	0.00226	0.0057	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00223	0.00563	CbGpPWpGaD
Octreotide—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00221	0.00365	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—PTH—nephrolithiasis	0.00218	0.0055	CbGpPWpGaD
Octreotide—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00215	0.00356	CcSEcCtD
Octreotide—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00212	0.00351	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—PTH—nephrolithiasis	0.00209	0.00527	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00206	0.00519	CbGpPWpGaD
Octreotide—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00205	0.00339	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—PTH—nephrolithiasis	0.00204	0.00515	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CHRM3—nephrolithiasis	0.00202	0.00511	CbGpPWpGaD
Octreotide—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00198	0.00328	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—DGKH—nephrolithiasis	0.00194	0.00491	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00194	0.00491	CbGpPWpGaD
Octreotide—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00191	0.00315	CcSEcCtD
Octreotide—Rash—Hydrochlorothiazide—nephrolithiasis	0.00189	0.00313	CcSEcCtD
Octreotide—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00189	0.00312	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—PTH—nephrolithiasis	0.00188	0.00475	CbGpPWpGaD
Octreotide—Headache—Hydrochlorothiazide—nephrolithiasis	0.00188	0.00311	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—CHRM3—nephrolithiasis	0.00187	0.00472	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00186	0.00471	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—DGKH—nephrolithiasis	0.00186	0.00471	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CHRM3—nephrolithiasis	0.00185	0.00468	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PTH—nephrolithiasis	0.00185	0.00467	CbGpPWpGaD
Octreotide—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00178	0.00295	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—PTH—nephrolithiasis	0.00171	0.00431	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PTH—nephrolithiasis	0.0017	0.00428	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00165	0.00418	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—DGKH—nephrolithiasis	0.00165	0.00418	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00152	0.00385	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—DGKH—nephrolithiasis	0.00152	0.00385	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CHRM3—nephrolithiasis	0.0014	0.00355	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CHRM3—nephrolithiasis	0.00135	0.0034	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PTH—nephrolithiasis	0.00129	0.00325	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PTH—nephrolithiasis	0.00123	0.00311	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CHRM3—nephrolithiasis	0.00119	0.00302	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CHRM3—nephrolithiasis	0.0011	0.00279	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PTH—nephrolithiasis	0.00109	0.00276	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PTH—nephrolithiasis	0.00101	0.00255	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—SPP1—nephrolithiasis	0.000851	0.00215	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—SPP1—nephrolithiasis	0.000645	0.00163	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—SPP1—nephrolithiasis	0.000618	0.00156	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SPP1—nephrolithiasis	0.000549	0.00139	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SPP1—nephrolithiasis	0.000506	0.00128	CbGpPWpGaD
